BRLZBasic Region Leucine Zipper
References in periodicals archive ?
The currently outstanding BRLZ shares are proposed to be reverse split approximately 1 for 27, resulting in 356,000 post-reverse split shares, and BRLZ will then issue a total of 8,724,000 post-reverse split shares to XENIX's shareholders and others.
The completion of the proposed transaction is subject to, among other things, satisfactory due diligence by both BRLZ and EES, the signing of a definitive agreement, approval by the shareholders of EES and the filing of an information statement to the Biorelease holders as of the record date.
BRLZ is a fully reporting publicly traded company whose common stock is traded over-the-counter on the Electronic Bulletin Board (OTCBB) under the symbol "BRLZ".